Coherent, Inc. provides lasers and laser-based technology in a range of scientific, commercial, and industrial applications worldwide. It operates through two segments, Specialty Lasers and Systems, and Commercial Lasers and Components. The company designs, manufactures, services, and markets lasers, laser tools, precision optics, and related accessories. Its products are used in markets, such as microelectronics, materials processing, original equipment manufacturer components and instrumentation, and scientific research and government programs. The company markets its products through a direct sales force in the United States, as well as through direct sales personnel and independent representatives internationally. Coherent Inc. was founded in 1966 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Analytical instruments
Sub-IndustryElectronic Equipment & Instruments
SectorComputer and Technology
SymbolNASDAQ:COHR
CUSIP19247910
Phone408-764-4000
Debt
Debt-to-Equity Ratio0.34
Current Ratio3.28
Quick Ratio1.87
Price-To-Earnings
Trailing P/E Ratio14.41
Forward P/E Ratio13.79
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.72 billion
Price / Sales2.55
Cash Flow$17.2552 per share
Price / Cash10.50
Book Value$47.23 per share
Price / Book3.84
Profitability
EPS (Most Recent Fiscal Year)$12.57
Net Income$207.12 million
Net Margins12.84%
Return on Equity28.01%
Return on Assets14.95%
Miscellaneous
Employees5,218
Outstanding Shares24,300,000
Market Cap$4.38 billion
Coherent (NASDAQ:COHR) Frequently Asked Questions
What is Coherent's stock symbol?
Coherent trades on the NASDAQ under the ticker symbol "COHR."
How will Coherent's stock buyback program work?
Coherent announced that its board has initiated a stock repurchase plan on Thursday, February 8th 2018, which authorizes the company to repurchase $100,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company's board of directors believes its shares are undervalued.
How were Coherent's earnings last quarter?
Coherent, Inc. (NASDAQ:COHR) announced its earnings results on Tuesday, July, 31st. The scientific and technical instruments company reported $3.51 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.54 by $0.03. The scientific and technical instruments company earned $482 million during the quarter, compared to analysts' expectations of $491.31 million. Coherent had a net margin of 12.84% and a return on equity of 28.01%. The firm's revenue was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.36 EPS. View Coherent's Earnings History.
When is Coherent's next earnings date?
What price target have analysts set for COHR?
7 Wall Street analysts have issued 12-month target prices for Coherent's shares. Their predictions range from $190.00 to $320.00. On average, they expect Coherent's stock price to reach $235.7143 in the next year. This suggests a possible upside of 30.1% from the stock's current price. View Analyst Price Targets for Coherent.
What is the consensus analysts' recommendation for Coherent?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Coherent in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Coherent.
What are Wall Street analysts saying about Coherent stock?
Here are some recent quotes from research analysts about Coherent stock:
- 1. According to Zacks Investment Research, "Coherent, Inc. is an American company, designs, manufactures and markets laser systems and components, laser measurement and control products, optics, and laser accessories, which are used both in industry and scientific research. Their markets are the microelectronics industry (e.g., flat panel display manufacturing, integrated circuit packaging, and integrated circuit inspection), scientific research, OEM components, and materials processing (e.g., CO2 lasers for cutting metals). " (7/31/2018)
- 2. Needham & Company LLC analysts commented, "IPHI reported in-line 4Q17 results but provided 1Q18 guidance meaningfully below our and the Street’s estimates that were reduced just three weeks ago. While IPHI continues to see an inventory correction in the China coherent long-haul/ metro market, other recent market developments have led to newer headwinds in the near term. Management still expects to see a recovery in its TIA/driver business starting in 2Q18 and continuing throughout FY18, and new products ramps in 2H18 are expected to contribute to higher GMs and EPS growth. While we remain positive about IPHI’s long-term prospects, we lower our estimates and PT to $35 from $45 to reflect the lower revenue trough. We are aggressive buyers below $26." (2/8/2018)
- 3. Benchmark Co. analysts commented, "We believe it is likely that Apple will employ OLED displays in all its iPhones by no later than 2019 and that other smartphone manufacturers will shift to OLED displays during this period." (10/12/2017)
Are investors shorting Coherent?
Coherent saw a increase in short interest during the month of July. As of July 31st, there was short interest totalling 2,359,131 shares, an increase of 27.8% from the July 13th total of 1,845,697 shares. Based on an average daily trading volume, of 477,900 shares, the short-interest ratio is presently 4.9 days. Currently, 9.6% of the company's stock are short sold. View Coherent's Current Options Chain.
Who are some of Coherent's key competitors?
Some companies that are related to Coherent include Waters (WAT), Mettler-Toledo International (MTD), Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), PerkinElmer (PKI), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bruker (BRKR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Harvard Bioscience (HBIO), Eyepoint Pharmaceuticals (EYPT), HTG Molecular Diagnostics (HTGM) and Arrayit Corp common stock (ARYC).
Who are Coherent's key executives?
Coherent's management team includes the folowing people:
- Dr. John R. Ambroseo, Pres, CEO & Director (Age 57)
- Mr. Kevin S. Palatnik, Exec. VP & CFO (Age 60)
- Mr. Bret M. DiMarco, Exec. VP, Gen. Counsel & Corp. Sec. (Age 50)
- Mr. Paul F. Sechrist, Exec. VP of Worldwide Sales & Services (Age 59)
- Dr. Mark S. Sobey, Exec. VP & GM of OEM Laser Sources (Age 58)
Has Coherent been receiving favorable news coverage?
Media headlines about COHR stock have been trending somewhat positive on Monday, Accern Sentiment reports. The research group scores the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Coherent earned a media and rumor sentiment score of 0.12 on Accern's scale. They also gave news headlines about the scientific and technical instruments company an impact score of 46.13 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View Recent Headlines for Coherent.
Who are Coherent's major shareholders?
Coherent's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.17%), Eagle Asset Management Inc. (4.59%), OppenheimerFunds Inc. (4.54%), Carillon Tower Advisers Inc. (3.28%), Epoch Investment Partners Inc. (2.62%) and Artisan Partners Limited Partnership (1.97%). Company insiders that own Coherent stock include Bret Dimarco, Garry W Rogerson, Jay T Flatley, John Ambroseo, Luis Spinelli, Mark Stewart Sobey, Paul F Sechrist, Sandeep Vij and Stephen A Skaggs. View Institutional Ownership Trends for Coherent.
Which institutional investors are selling Coherent stock?
COHR stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Eagle Asset Management Inc., Handelsbanken Fonder AB, SG Americas Securities LLC, Janus Henderson Group PLC, Royce & Associates LP, Dana Investment Advisors Inc. and Great West Life Assurance Co. Can. Company insiders that have sold Coherent company stock in the last year include Bret Dimarco, Jay T Flatley, John Ambroseo, Mark Stewart Sobey, Paul F Sechrist, Sandeep Vij and Stephen A Skaggs. View Insider Buying and Selling for Coherent.
Which institutional investors are buying Coherent stock?
COHR stock was acquired by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Sterling Capital Management LLC, Wells Fargo & Company MN, BlackRock Inc., Oakview Capital Management L.P., LSV Asset Management, State of New Jersey Common Pension Fund D and Artisan Partners Limited Partnership. View Insider Buying and Selling for Coherent.
How do I buy shares of Coherent?
Shares of COHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Coherent's stock price today?
One share of COHR stock can currently be purchased for approximately $181.18.
How big of a company is Coherent?
Coherent has a market capitalization of $4.38 billion and generates $1.72 billion in revenue each year. The scientific and technical instruments company earns $207.12 million in net income (profit) each year or $12.57 on an earnings per share basis. Coherent employs 5,218 workers across the globe.
How can I contact Coherent?
Coherent's mailing address is 5100 Patrick Henry Drive, Santa Clara CA, 95054. The scientific and technical instruments company can be reached via phone at 408-764-4000.
MarketBeat Community Rating for Coherent (NASDAQ COHR)
MarketBeat's community ratings are surveys of what our community members think about Coherent and other stocks. Vote "Outperform" if you believe COHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COHR will underperform the S&P 500 over the long term. You may vote once every thirty days.
